The Future of Weight Loss Therapies—Food Intake Versus Energy Expenditure
Insights into Diabetic Kidney Disease—Top Research
Insights into Metabolic Dysfunction in the Liver
Standards of Care in Overweight and Obesity
Debate - If You Had to Pick Just One—GLP-1RA, GIP/GLP-1RA or SGLT2i for Type 2 Diabetes?
Evidence for Combination Therapy
Advancing Effective and Equitable Treatment of Hyperglycemia in Pregnancy
Decoding Alpha- and Beta-Cell Function
Screening and Primary Prevention Strategies for ASCVD in Diabetes
Controversies in Continuous Glucose Monitoring
Peripartum Management of Diabetes
Skeletal Muscle Dysfunction in Metabolic Disease
Opening a Door to Precision Medicine
Patient Journeys in Diabetes: Reducing Burden with Personalized Monitoring and Management
The Amylin Adventure: Understanding the Role of Amylin in Obesity as an Emerging Therapeutic Target
Implementing the MASH Care Pathway - An Interactive Case Challenge
Clinical Applications of Artificial Intelligence and Diabetes
A Comprehensive View to Improving Health Care
Addressing the Residual Cardiovascular Risk in People with Diabetes
Unusual Types of Diabetes
Understanding the Type 1 Diabetes Journey:
Uncovering the Power of UACR: An Early Signal of CV Risk
Time-Restricted Eating on Glucose Tolerance and Body Weight
Artificial Intelligence vs. Human Coaching for Diabetes
The Cost Chiasm—Therapeutics, Technologies, and Care
What’s New with Interpretation of CGM Metrics and Relationship to A1C, eA1C and GMI?
How Can We Better Understand Obesity?
Not All Obesity is the Same
GLP-1RAs—Miracle Drug or Behavioral Health Minefield?
Weight Loss in Pregnancy with Obesity—Risky Gamble or Beneficial Bet?
What Is the Best Way to Measure the Burden and Severity of Hypoglycemia in People Living with Diabetes?
Unveiling Novel Mechanisms and Urogenital Autonomic Dysfunction
Remembering Type 1 Diabetes in the Kidney Therapeutics Revolution
The Overlooked Organ—Optimizing Liver Health in Diabetes Management
The Hypoglycemia Risk Profile—Leveraging Disparate Methods to Identify and Phenotype Those at Risk
What’s New with Continuous Glucose Monitoring?
Pharmacologic Interventions to Modulate Insulin Resistance
Obesity Sarcopenia
Benefits of Exercise Training in Combination for Weight Loss
